LESI | Print Page | Sign In | Join
LES (USA & Canada) Editorial Board
Share |

LES (USA & Canada) Editorial Board

Brian Frizzell, Director, Capstone Advisory Group

Chemicals, Energy, Environment & Materials Sector
Ida Shum, Sr. Manager, Business Development, Samsung – Open Innovation Center

Consumer Products Sector
Susan Levy, Consultant

High Technology Sector
Michael Crowley
, Products & Technology Counsel, Baker Hughes

Industry-University-Government Interface Sector
Matt Raymond
, Director of Intellectual Property, Rush University Medical Center

John Paul
, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Licensing Office and Structure Management
Matt Raymond
, Director of Intellectual Property, Rush University Medical Center

Life Sciences Sector
Fernando Salles, External Scientific Affairs, Merck Research Laboratories

Valuation & Taxation
Chris Schulte
, Director, 284 Partners, LLC
Bruce Berman, CEO, Brody Berman Associate., Inc.

Women in Licensing
Adrienne Robinson, Director, Merck & Co., Inc.

Board Bios

Michael Crowley, Senior Licensing Counsel, Research in Motion
Michael Crowley is Senior Licensing Counsel with Research In Motion. At RIM, he is responsible for managing patent licensing matters, including evaluating patents for inbound licensing and conducting licensing negotiations. Prior to joining RIM, he prepared and prosecuted patent applications before the U.S. Patent and Trademark Office and before foreign patent offices in several technology areas, including communications systems and equipment. Prior to graduating from law school, he worked as a product development engineer and was responsible for the design and development of data communication equipment.

Mr. Crowley earned his B.S. in Electrical Engineering from Rochester Institute of Technology and his J.D. degree, cum laude, from the University of Miami School of Law. He is admitted to the Bar of North Carolina, and he is registered to practice before the United States Patent and Trademark Office.

Brian Frizzell, Director, Capstone Advisory Group
Brian Frizzell has over a decade of experience in intellectual property litigation, valuation, strategy, and licensing across a wide range of industries and technologies. He specializes in analyzing the economic contribution of intellectual property to the commercial success of the relevant products to determine the corresponding value.  He has developed damages analyses that have been presented in federal court in a variety of jurisdictions and has valued patent portfolios for transactional purposes and as part of bankruptcy proceedings. Mr. Frizzell received a B.S. in Electrical Engineering from the University of Illinois at Urbana-Champaign and a Masters in Business Administration from the Kellogg Graduate School of Management at Northwestern University. He is a member of the Licensing Executives Society where he is a past chair of the valuation & taxation committee. Mr. Frizzell is an adjunct lecturer at the University of Illinois and has presented on patent damages, valuation and IP strategy at both the Urbana and Chicago campuses.

Susan Levy, Consultant
Susan Levy has over 20 years of global, cross-functional experience in the pharmaceutical/consumer healthcare industry and a successful track record of helping companies grow brands and product portfolios through internal innovation, technology licensing, external alliances and acquisitions. She has been involved in Rx-to-OTC switch thinking, evaluation, licensing and commercialization at leading companies such as SmithKline Beecham, Warner-Lambert, Pfizer and Schering-Plough.

John Paul, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
John Paul is a partner in the law firm of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP and is based in the Washington D.C. office. He has over 30 years of experience in intellectual property licensing, litigation, and prosecution. He currently focuses on strategic planning, complex transactions, due diligence investigations, and licensing and enforcement of IP portfolios to generate revenue. He chairs the firm’s IP management and transaction section.

Mr. Paul has analyzed numerous patent portfolios for a wide range of companies and provided strategy on building portfolios and exploiting patents to help those companies understand the legal and commercial significance of IP portfolios, develop more robust portfolios aligned with their business objectives, and generate revenue by monetizing those portfolios.

He has set up and directed licensing and enforcement programs that generated significant royalty revenue for leading technology companies, set up and conducted multiple-round private auctions to sell patent portfolios, led the negotiations for IP issues in business divestitures and other complex transactions, and led the IP due diligence and negotiations for strategic acquisitions of patent portfolios.

The technologies and industries involved in his work include multimedia electronics, aerospace, medical devices, and consumer products.

Mr. Paul has been a trustee, vice president, and counsel to the Licensing Executives Society U.S.A. and Canada.

Matt Raymond, Director of Intellectual Property, Rush University Medical Center
Dr. Raymond is an experienced business development professional with the responsibility for technology transfer at Rush University Medical Center in Chicago. Matt trained in technology transfer at the University of Virginia and The University of Chicago. He is a co-founder of two biomedical companies and has been actively involved at various stages in several dozen others. Matt initially worked as an Investigator in both discovery and clinical development for SmithKline Beecham Animal Health where he received US and international patents for his discoveries. Dr. Raymond received his BS and PhD in Biochemistry from the University of Wyoming and his MBA from the University of Virginia’s Darden Graduate School of Business. He is a registered Patent Agent with the USPTO and a Certified Licensing Professional.

Adrienne Robinson, Director, Merck & Co., Inc.
Adrienne Robinson has a 25+ year diverse professional background having worked in Research, Manufacturing Operations, Logistics, Supply Chain, Human Resources, Finance, and Corporate Procurement at Merck and Procter & Gamble. Adrienne has certification as a Certified Licensing Professional, a Bachelor of Science degree in Engineering Chemistry from Colorado School of Mines, a Master of Business Administration degree from The Pennsylvania State University, as well as Master of Science from University of Texas in Technology Commercialization. She is a Director at Merck supporting licensing, acquisitions, and divestiture business opportunities. Her passion lies is bringing together disparate concepts and teams to enable new thinking and innovation to advance business objectives. Additionally, Adrienne has had a long term commitment of increasing the impact of women’s development and leadership in the workplace. Adrienne is a chapter Board Member of Soroptimist’s which is an international volunteer organization working to improve the lives of women and girls, in local communities and throughout the world. Additionally, she is a Metro Chapter Board Member for the Healthcare Business Women’s Association, serving as the Director Corporate Relations in addition to serving on the LES Editorial Board.

Fernando Salles, External Scientific Affairs, Merck Research Laboratories
For the past 13 years Fernando has been actively involved in strategy, licensing and business development activities both at biotechnology and pharmaceutical companies.

He has broad experience negotiating licensing and acquisition agreements and has directed financial assessments of opportunities as well as managed portfolio analytics. He is currently Executive Director, Strategic Licensing & Acquisitions Lead at Merck and an adjunct faculty at SUNY, Stony Brook in the Department of Pharmacology. Fernando earned his PhD in molecular pharmacology and spent 9 years thereafter guiding and conducting research in academic/not-for-profit institutions. He is a member of the Licensing Executive Society and has obtained a Certified Licensing Professional (CLP) certification.

Chris Schulte, Director, 284 Partners, LLC
Chris Schulte is a Director at 284 Partners, LLC, a professional services firm dedicated to advising clients on financial aspects of IP in valuation, litigation, strategic, and transactional contexts. His practice concentrates on the valuation of IP and the determination of economic damages in IP litigation. Many of Mr. Schulte’s past engagements have included the evaluation of financial and accounting data in order to quantify lost profits, reasonable royalties, unjust enrichment, or diminished business value. Mr. Schulte has also supported clients in license negotiations and other business transactions. Mr. Schulte is the Chair-Elect of the Valuation and Taxation Committee of LES and a CLP.

Ida Shum, Sr. Manager, Business Development, Samsung - Open Innovation Center
Ida C. Shum is a Sr. Manager for Business Development at Samsung - Open Innovation Center. Previously, Ida was a Business Development Executive for Lawrence Livermore National Laboratory. She was responsible for the commercialization of technologies in the areas relating to biotechnology, chemistry and materials. Ida was also at the Idaho National Laboratory commercializing technologies covering national security, industrial processes, robotics, and materials. She has spent the last seven years creating technology partnerships with industrial, private entities, and academic partners. Ida assumed the Sector's leadership position in fall 2011 with plans to continue to promote positive interface between industry, universities, and government agencies. In her spare time, Ida enjoys photography and hiking the national parks.


11130 Sunrise Valley Drive, Suite 350 Reston, VA 20191 Phone: 703-234-4058 Fax: 703-435-4390